Latest news with #MedPlus
Business Standard
28-05-2025
- Business
- Business Standard
Medplus Health hits 52-week high after Q4 PAT rises 54% YoY to Rs 52 cr
Medplus Health Services added 3.50% to Rs 983.55 after the company's consolidated net profit jumped 53.7% to Rs 51.34 crore on 1.3% increase in revenue from operations to Rs 1509.61 crore in Q4 FY25 over Q4 FY24. Profit before tax (PBT) jumped 91.1% YoY to Rs 61.12 crore in the quarter ended 31st March 2025. Operating EBITDA stood at Rs 80.33 crore, registering the growth of 38.2% compared with Rs 58.13 crore posted in same quarter last year. Operating EBITDA margin improved to 5.3% in Q4 FY25 as against 3.9% in Q4 FY24. In Q4 FY25, the company added 100 stores. As on 31st March 2025, the total store count stood at 4,712. On full year basis, the companys consolidated net profit surged 129.6% to Rs 150.32 crore on 9.1% increase in revenue from operations to Rs 6,136.05 crore in FY25 over FY24. Meanwhile, the companys board approved the appointment of Subrahmanyam Sharma Tatapudi, as chief technology officer (CTO), (earlier serving as deputy chief technology officer), with effect from 27 May 2025. MedPlus Health Services (MedPlus) is an organized pharmacy retail company with both an online and offline presence. The company operates in retail and wholesale sales, import, distribution, manufacturing and contract manufacturing of private-label pharmaceuticals, wellness and FMCG products and full-fledged diagnostic centers. The counter hits 52-week high at Rs 1,052.05 in intraday today.
Reuters
31-01-2025
- Business
- Reuters
India's MedPlus Health Q3 profit triples on strong OTC drug demand
Jan 31 (Reuters) - India's MedPlus Health Services ( opens new tab reported a surge in third-quarter profit on Friday, driven by store expansions and strong demand for over-the-counter medicines. The company's consolidated net profit more than tripled to 458.8 million rupees ($5.3 million) in the quarter ended Dec. 31. MedPlus continued to benefit from strong sales of products under its private label brands in both the pharmaceuticals and consumer wellness categories, which analysts say contribute more to its margins. The company's revenue from operations rose 8.3% to 15.61 billion rupees, led by an 8% jump in its retail business. While MedPlus does not break up its revenue from OTC medicines and devices, etc, they are all part of its retail business, which makes up nearly all of the company's revenue. The company currently has more than 4,000 outlets across the country, trailing only Apollo Pharmacy's count of nearly 6,000 stores. Last year, MedPlus said it plans to open 600 stores to increase its presence in smaller cities. MedPlus competes with Reliance Industries' ( opens new tab Netmeds and Apollo Pharmacy, both of which are unlisted, among other retail pharmacies in the Indian OTC drug retail market. ($1 = 86.5830 Indian rupees) Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
